GR3020426T3 - A process for anomerizing nucleosides - Google Patents

A process for anomerizing nucleosides

Info

Publication number
GR3020426T3
GR3020426T3 GR960401799T GR960401799T GR3020426T3 GR 3020426 T3 GR3020426 T3 GR 3020426T3 GR 960401799 T GR960401799 T GR 960401799T GR 960401799 T GR960401799 T GR 960401799T GR 3020426 T3 GR3020426 T3 GR 3020426T3
Authority
GR
Greece
Prior art keywords
nucleosides
anomerizing
anomer
anomeric mixture
nucleoside
Prior art date
Application number
GR960401799T
Other languages
Greek (el)
English (en)
Inventor
Thomas Charles Britton
Tourneau Michael Edward Le
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3020426T3 publication Critical patent/GR3020426T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR960401799T 1992-09-01 1996-07-02 A process for anomerizing nucleosides GR3020426T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93879192A 1992-09-01 1992-09-01

Publications (1)

Publication Number Publication Date
GR3020426T3 true GR3020426T3 (en) 1996-10-31

Family

ID=25471966

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401799T GR3020426T3 (en) 1992-09-01 1996-07-02 A process for anomerizing nucleosides

Country Status (15)

Country Link
US (1) US5420266A (da)
EP (1) EP0587364B1 (da)
JP (1) JP3462893B2 (da)
KR (1) KR100252451B1 (da)
AT (1) ATE138929T1 (da)
BR (1) BR9303658A (da)
CA (1) CA2105112C (da)
DE (1) DE69302977T2 (da)
DK (1) DK0587364T3 (da)
ES (1) ES2090880T3 (da)
GR (1) GR3020426T3 (da)
HU (1) HU214980B (da)
IL (1) IL106840A (da)
MX (1) MX9305301A (da)
TW (1) TW356472B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
CA2171518A1 (en) * 1995-03-24 1996-09-25 Douglas Patton Kjell Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides
US5633367A (en) * 1995-03-24 1997-05-27 Eli Lilly And Company Process for the preparation of a 2-substituted 3,3-difluorofuran
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
US6248878B1 (en) * 1996-12-24 2001-06-19 Ribozyme Pharmaceuticals, Inc. Nucleoside analogs
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CA2410579C (en) 2000-05-26 2010-04-20 Jean-Pierre Sommadossi Methods and compositions for treating flaviviruses and pestiviruses
KR100467016B1 (ko) * 2002-05-30 2005-01-24 삼성전자주식회사 반도체기판의 세정방법
JP2005533824A (ja) 2002-06-28 2005-11-10 イデニクス（ケイマン）リミテツド フラビウイルス科感染の治療のための２’−ｃ−メチル−３’−ｏ−ｌ−バリンエステルリボフラノシルシチジン
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
MXPA05005192A (es) 2002-11-15 2005-09-08 Idenix Cayman Ltd Nucleosidos ramificados en la posicion 2' y mutacion de flaviviridae.
BRPI0419345B8 (pt) * 2003-05-30 2021-05-25 Gilead Pharmasset Llc uso do (2’r)-2’-desoxi-2’-flúor-2’-c-metil nucleosídeo e de uma composição farmacêutica que o compreende
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
RU2433124C2 (ru) * 2004-09-14 2011-11-10 Фармассет, Инк. Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
MX2007010316A (es) * 2005-03-04 2008-02-19 Dabur Pharma Ltd Intermediario de 21-desoxi, 21,21-difluoro-d-ribofuranosil nucleosidos enriquecidos en (-anomero y proceso para prepararlo.
CA2634749C (en) 2005-12-23 2014-08-19 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US7964580B2 (en) * 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
SG172361A1 (en) * 2008-12-23 2011-07-28 Pharmasset Inc Nucleoside analogs
EP2376515A1 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthesis of purine nucleosides
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
PT3290428T (pt) 2010-03-31 2021-12-27 Gilead Pharmasset Llc Comprimido compreendendo 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2h)-il)¿4¿fluoro¿3¿hidroxi¿4¿metiltetrahidrofuran¿2¿il)metoxi) (fenoxi)fosforil)amino)propanoato de (s)- isopropil cristalino
PT3042910T (pt) 2010-11-30 2019-04-16 Gilead Pharmasset Llc 2'-espiro-nucleósidos para utilização na terapia da hepatite c
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CN102603838B (zh) * 2012-02-14 2015-02-18 江苏八巨药业有限公司 一种制备吉西他滨盐酸盐的方法
AU2014311827B2 (en) 2013-08-27 2017-09-14 Gilead Sciences, Inc. Combination formulation of two antiviral compounds
AU2019296174B2 (en) 2018-06-29 2021-10-07 Changchun Changcheng Pharmaceutical Technology Co., LTD Phosphorus-containing prodrugs of gemcitabine

Also Published As

Publication number Publication date
EP0587364B1 (en) 1996-06-05
KR940007053A (ko) 1994-04-26
DE69302977T2 (de) 1996-10-31
MX9305301A (es) 1994-06-30
IL106840A (en) 1998-09-24
CA2105112C (en) 2005-08-02
US5420266A (en) 1995-05-30
CA2105112A1 (en) 1994-03-02
EP0587364A1 (en) 1994-03-16
HUT65137A (en) 1994-04-28
KR100252451B1 (ko) 2000-04-15
DE69302977D1 (de) 1996-07-11
HU9302452D0 (en) 1993-11-29
HU214980B (hu) 1998-08-28
JP3462893B2 (ja) 2003-11-05
BR9303658A (pt) 1994-03-22
TW356472B (en) 1999-04-21
ATE138929T1 (de) 1996-06-15
JPH06157571A (ja) 1994-06-03
IL106840A0 (en) 1993-12-08
DK0587364T3 (da) 1996-07-01
ES2090880T3 (es) 1996-10-16

Similar Documents

Publication Publication Date Title
IL106840A0 (en) A process for anomerizing nucleosides
TW224101B (da)
UA41261C2 (uk) Спосіб одержання збагачених бета-аномером нуклеозидів
IL106079A0 (en) 2'-deoxy-2',2'-difluoro(4-substituted pyrimidine)nucleosides having anti-viral and anti-cancer activity and intermediates
IL106076A0 (en) Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonates
NO932286L (no) Stereoselektiv anion-glykosyleringsprosess
HUT64551A (en) A method for spearating 2-desoxi-2,2-difluorine-d-ribo furanosyle-alkyl-sulfonate anomers
DE69322265D1 (en) Alkylthioalkylavermectine sind aktive antiparasitäre wirkstoffe
JPS565497A (en) Novel manufacture of 5**deoxyy55fluorouridine
GB8808001D0 (en) Stereospecific preparative process for furol(3,4-c)pyridine derivatives
AU1177492A (en) Structural module for a vehicle door
EP0640614A3 (en) Stereoselective process for the preparation of beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy-protected 1-alkyl and aryl sulfonate intermediates.
NZ238521A (en) Process for the conversion of avermectin glycone to avermectin mono- and disaccharides by fermentation with streptomyces avermitilis ma6078
IL102143A0 (en) Process for selectively isolating 2-deoxy-2,2-difluoro-d-erythro-pentofuranos-1-ulose-3,5-dibenzoate
EP1052265A4 (en) PROCESS FOR PREPARING NUCLEOSIDE DERIVATIVES
HUT62909A (en) Process for the selective isolation of 2-deoxy-2,2-difluoro-d-erythropentafuranose-1-ulose-3,5-dibenzoate from enentiomer mixture
RU93046506A (ru) Способ получения нуклеозидов